Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe COVID-19”

116 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 116 results

Large-scale testing (Phase 3)Ended earlyNCT05279235
What this trial is testing

Efficacy and Safety of JT001 (VV116) Compared With Favipiravir

Who this might be right for
Moderate to Severe COVID-19
Shanghai Vinnerna Biosciences Co., Ltd. 290
Testing effectiveness (Phase 2)UnknownNCT04920760
What this trial is testing

Vitamin A Supplementation in Children With Moderate to Severe COVID-19

Who this might be right for
Covid19
Shiraz University of Medical Sciences 60
Early research (Phase 1)Study completedNCT04582201
What this trial is testing

A Clinical Trial to Evaluate the Safety of agenT-797 in COVID-19 Participants With ARDS

Who this might be right for
Respiratory Distress Syndrome, Adult
MiNK Therapeutics 20
Testing effectiveness (Phase 2)WithdrawnNCT04561180
What this trial is testing

Study to Evaluate the Efficacy and Safety of EG-009A Compared to DEX in Patients With COVID-19 Pneumonia

Who this might be right for
COVID-19 Pneumonia
Evergreen Therapeutics, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT05156671
What this trial is testing

Adrecizumab (HAM8101) to Improve Prognosis and Outcomes in COVID-19 Trial

Who this might be right for
COVID-19
Universitätsklinikum Hamburg-Eppendorf 16
Testing effectiveness (Phase 2)Study completedNCT04701658
What this trial is testing

A Real World Study of Bamlanivimab in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

Who this might be right for
COVID-19
Eli Lilly and Company 109
Testing effectiveness (Phase 2)Ended earlyNCT04416048
What this trial is testing

Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19

Who this might be right for
COVID-19
Charite University, Berlin, Germany 111
Testing effectiveness (Phase 2)Study completedNCT04453384
What this trial is testing

Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia

Who this might be right for
SARS Virus
Nantes University Hospital 416
Post-approval studies (Phase 4)UnknownNCT04350684
What this trial is testing

Umifenovir in Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
Shahid Beheshti University of Medical Sciences 40
Testing effectiveness (Phase 2)WithdrawnNCT05085574
What this trial is testing

Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)

Who this might be right for
2019 Novel Coronavirus Disease2019 Novel Coronavirus Infection2019-nCoV Disease+9 more
Leidos Life Sciences
Post-approval studies (Phase 4)Study completedNCT04952857
What this trial is testing

Short Term, High Dose Vitamin D Supplementation in Moderate to Severe COVID-19 Disease

Who this might be right for
Covid19
Post Graduate Institute of Medical Education and Research, Chandigarh 90
Large-scale testing (Phase 3)Study completedNCT06585319
What this trial is testing

Pirfenidone LP or Collagen-polyvinylpyrrolidone in COVID-19

Who this might be right for
COVID 19
Materno-Perinatal Hospital of the State of Mexico 36
Not applicableAvailableNCT04657406
What this trial is testing

Expanded Access to Zofin for Patients With COVID-19

Who this might be right for
Covid19Corona Virus InfectionSARS (Severe Acute Respiratory Syndrome)+1 more
ZEO ScientifiX, Inc.
Large-scale testing (Phase 3)Study completedNCT05999435
What this trial is testing

Study of LAU-7b for the Treatment of Long COVID in Adults

Who this might be right for
Long COVID
Laurent Pharmaceuticals Inc. 272
Large-scale testing (Phase 3)Ended earlyNCT04695704
What this trial is testing

Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19:

Who this might be right for
Covid19SARS (Disease)
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 86
Large-scale testing (Phase 3)Ended earlyNCT04492358
What this trial is testing

Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population, Admitted to a Geriatric Hospital Unit or in a Transicional Care Center

Who this might be right for
Covid19
Maria Joyera Rodríguez 54
Testing effectiveness (Phase 2)Study completedNCT04625738
What this trial is testing

Efficacy of Infusions of MSC From Wharton Jelly in the SARS-Cov-2 (COVID-19) Related Acute Respiratory Distress Syndrome

Who this might be right for
COVID19 ARDS
Central Hospital, Nancy, France 30
Large-scale testing (Phase 3)Ended earlyNCT04371393
What this trial is testing

MSCs in COVID-19 ARDS

Who this might be right for
Mesenchymal Stromal CellsRemestemcel-LAcute Respiratory Distress Syndrome+1 more
Icahn School of Medicine at Mount Sinai 223
Early research (Phase 1)Ended earlyNCT04762186
What this trial is testing

Viable Human SARS-CoV-2 Specific T Cell Transfer in Patients at Risk for Severe COVID-19

Who this might be right for
Moderate COVID-19-infection
Universitätsklinikum Köln 1
Large-scale testing (Phase 3)UnknownNCT04516811
What this trial is testing

Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19

Who this might be right for
COVID-19SARS-CoV-2 InfectionSevere Acute Respiratory Syndrome Coronavirus 2
South African National Blood Service 600
Load More Results